Fig. 1From: Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoLa and b EPP Symptoms and EPP Wellbeing over time. Plots show median (broad bar), interquartile range or IQR (brown box), 1.5 times IQR (whiskers), circles and stars are outliersBack to article page